Compliance with Model Code

Finsbury Worldwide Pharmaceutical Trust PLC

1 October 2009

          Finsbury Worldwide Pharmaceutical Trust PLC (the'Company')           

           Listing Rule 15.5.1 (4) - Transactions in a Close Period            

In accordance with Listing Rule 15.5.1 (4), the Directors of the Company
confirm that they are satisfied that all inside information that the Directors
and the Company have up until the date of this notice has been notified to a
Regulated Information Service ("RIS") and that any further inside information
leading up to the announcement of the interim results for the six months to 30
September 2009 will be notified to a RIS.

The Company is therefore exempt during the close period from the provisions of
the Model Code in respect of dealings by persons discharging managerial
responsibilities and purchases of its own securities. If, in the period leading
up to the announcement of the interim results, the Directors or the Company
come into possession of any inside information, this will be notified to a RIS
before any such transactions are undertaken.

Frostrow Capital LLP

Company Secretary

1 October 2009